Clinical Trial

Zomedica Announces “Fourth Friday at Four” Webinar on September 25, 2026: Inside Zomedica’s Marketing Engine: How Demand Becomes Revenue

September session to spotlight how Zomedica's marketing function creates demand, equips the field, and supports utilization across the company's diagnostic...

Brainomix and Endeavor BioMedicines Present Positive Results from Quantitative Image Analysis of Phase 2a Idiopathic Pulmonary Fibrosis (IPF) Trial at ERS Congress

AI-powered quantitative CT analysis with Brainomix 360 e-Lung was used in Endeavor BioMedicines ENV-IPF-101 Phase 2a trial of taladegib. Results...

Clinical Trial for an Oral Drug to Treat Ebola is Registered in the Pan African Clinical Trials Database and is Ready to Go, As the Largest Ebola Outbreak Continues to Expand in DR Congo

Rhelion Life Sciences’ Wholly Owned Subsidiary Filament Health Completes Shipment of PEX010 to Australia for University of Melbourne Trial of Psilocybin-Assisted Physiotherapy in Functional Neurological Disorder

BioNxt Advances Sublingual Everolimus ODF for Organ Transplant Rejection with Initiation of Large-Animal Pharmacokinetic Study

VANCOUVER, BC / ACCESS Newswire / September 8, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience...

Additional Infant Patient to Receive Jaguar Health’s Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)

Jaguar remains sharply focused on its ongoing global development program for oral crofelemer as adjunctive therapy to parenteral support (PS)...

Rhelion Life Sciences Confirms Further Delivery of Filament Health’s PEX010 to Germany’s First Psilocybin Compassionate Use Program

Filament Health has completed a further international delivery of its patented, naturally derived psilocybin drug candidate PEX010 to Germany, supporting...

error: Content is protected !!